Item Type | Name |
Concept
|
Antigen-Antibody Complex
|
Concept
|
Antigens, Neoplasm
|
Concept
|
Antigen-Presenting Cells
|
Concept
|
Antigens, Viral
|
Concept
|
Bone Marrow Cells
|
Concept
|
Antigens
|
Concept
|
Antigens, Surface
|
Concept
|
Cell Communication
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Cell Differentiation
|
Concept
|
Cell Movement
|
Concept
|
Cell Membrane
|
Concept
|
Cell Division
|
Concept
|
Clone Cells
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Dendritic Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
HLA-D Antigens
|
Concept
|
Histocompatibility Antigens
|
Concept
|
H-2 Antigens
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
Concept
|
HLA-A2 Antigen
|
Concept
|
HLA-A Antigens
|
Concept
|
Antigens, Tumor-Associated, Carbohydrate
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
Th1 Cells
|
Concept
|
Cell Culture Techniques
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
CD8 Antigens
|
Concept
|
Receptors, Interleukin-2
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Antigen Presentation
|
Concept
|
B7-1 Antigen
|
Concept
|
Receptors, Tumor Necrosis Factor
|
Concept
|
Receptors, Interferon
|
Concept
|
Cell Proliferation
|
Concept
|
CD40 Antigens
|
Concept
|
Receptors, Tumor Necrosis Factor, Member 14
|
Concept
|
Jurkat Cells
|
Concept
|
B7-H1 Antigen
|
Concept
|
Platelet Endothelial Cell Adhesion Molecule-1
|
Concept
|
Interleukin-15 Receptor alpha Subunit
|
Concept
|
CTLA-4 Antigen
|
Concept
|
Cell Hypoxia
|
Concept
|
Killer Cells, Lymphokine-Activated
|
Concept
|
Thy-1 Antigens
|
Concept
|
Stromal Cells
|
Concept
|
CD3 Complex
|
Concept
|
Receptors, Chemokine
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22
|
Concept
|
Cell Lineage
|
Concept
|
CD11b Antigen
|
Concept
|
Endothelial Cells
|
Concept
|
Programmed Cell Death 1 Receptor
|
Concept
|
Cell Line, Tumor
|
Concept
|
Antigen-Antibody Reactions
|
Concept
|
Blood Cell Count
|
Concept
|
Carcinoembryonic Antigen
|
Concept
|
Cell Line
|
Concept
|
Cell Survival
|
Concept
|
Cells, Cultured
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Receptors, Virus
|
Concept
|
CD4 Antigens
|
Concept
|
Myeloid Cells
|
Academic Article
|
A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
|
Academic Article
|
DNA sequence analysis of T-cell receptor genes reveals an oligoclonal T-cell response to a tumor with multiple target antigens.
|
Academic Article
|
Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein.
|
Academic Article
|
Footprinting of individual tumors and their variants by constitutive cytokine expression patterns.
|
Academic Article
|
Genetically engineered vaccines. Comparison of active versus passive immunotherapy against solid tumors.
|
Academic Article
|
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
|
Academic Article
|
Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
|
Academic Article
|
The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68.
|
Academic Article
|
Radiation can inhibit tumor growth indirectly while depleting circulating leukocytes.
|
Academic Article
|
Unique tumor antigens redefined as mutant tumor-specific antigens.
|
Academic Article
|
Tumor cells induce cytolytic T cells to a single immunodominant mutant peptide.
|
Academic Article
|
Tracking the common ancestry of antigenically distinct cancer variants.
|
Academic Article
|
Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide.
|
Academic Article
|
Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens.
|
Academic Article
|
Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation.
|
Academic Article
|
Tumor antigens.
|
Academic Article
|
Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.
|
Academic Article
|
MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
|
Academic Article
|
C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum.
|
Academic Article
|
Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
|
Academic Article
|
Priming of naive T cells inside tumors leads to eradication of established tumors.
|
Academic Article
|
Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.
|
Academic Article
|
A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity.
|
Academic Article
|
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
|
Academic Article
|
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.
|
Academic Article
|
The role of stroma in immune recognition and destruction of well-established solid tumors.
|
Academic Article
|
Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18.
|
Academic Article
|
The terminology issue for myeloid-derived suppressor cells.
|
Academic Article
|
Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
|
Academic Article
|
Specificity in cancer immunotherapy.
|
Academic Article
|
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
|
Academic Article
|
Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells.
|
Academic Article
|
A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
|
Academic Article
|
Antibody recognition of a unique tumor-specific glycopeptide antigen.
|
Academic Article
|
Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
|
Academic Article
|
Densely granulated murine NK cells eradicate large solid tumors.
|
Academic Article
|
Cancer. Quo vadis, specificity?
|
Academic Article
|
Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity.
|
Academic Article
|
Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.
|
Academic Article
|
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
|
Academic Article
|
Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells.
|
Academic Article
|
Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.
|
Academic Article
|
Antigenic cancer cells that escape immune destruction are stimulated by host cells.
|
Academic Article
|
Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.
|
Academic Article
|
Targeting stroma to treat cancers.
|
Academic Article
|
CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells.
|
Academic Article
|
Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.
|
Academic Article
|
Spleen cells from young but not old immunized mice eradicate large established cancers.
|
Academic Article
|
A unique tumor antigen produced by a single amino acid substitution.
|
Academic Article
|
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
|
Academic Article
|
Cancer. Awakening immunity.
|
Academic Article
|
Unique tumor-specific antigens.
|
Academic Article
|
Identification of a gene encoding a tumor-specific antigen that causes tumor rejection.
|
Academic Article
|
Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
|
Academic Article
|
Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
|
Academic Article
|
[CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
|
Academic Article
|
Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines.
|
Academic Article
|
CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells.
|
Academic Article
|
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
|
Academic Article
|
CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.
|
Academic Article
|
Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
|
Academic Article
|
Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
|
Academic Article
|
Tumor-specific immune responses.
|
Academic Article
|
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.
|
Academic Article
|
[Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
|
Academic Article
|
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.
|
Academic Article
|
Tumor-specific antigens and tumor-specific mutant proteins in mouse and man.
|
Academic Article
|
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.
|
Academic Article
|
Immunodominance and tumor escape.
|
Academic Article
|
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
|
Academic Article
|
Bystander elimination of antigen loss variants in established tumors.
|
Academic Article
|
Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
|
Academic Article
|
Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.
|
Academic Article
|
In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
|
Academic Article
|
Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
|
Academic Article
|
Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients.
|
Academic Article
|
Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.
|
Academic Article
|
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.
|
Academic Article
|
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
|
Academic Article
|
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.
|
Academic Article
|
Design and characterization of a protein superagonist of IL-15 fused with IL-15Ra and a high-affinity T cell receptor.
|
Academic Article
|
[Clinical aspects and therapy of Merkel cell tumor--report of 4 personal cases and review of the literature].
|
Academic Article
|
Innate and adaptive immune cells in the tumor microenvironment.
|
Academic Article
|
Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.
|
Academic Article
|
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter.
|
Academic Article
|
Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.
|
Academic Article
|
Targeting cancer-specific mutations by T cell receptor gene therapy.
|
Academic Article
|
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
|
Academic Article
|
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
|
Academic Article
|
Tumor-associated fibroblasts predominantly come from local and not circulating precursors.
|
Academic Article
|
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.
|
Academic Article
|
Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.
|
Academic Article
|
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs).
|
Academic Article
|
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
|
Academic Article
|
Long-term Persistence of CD4+ but Rapid Disappearance of CD8+ T Cells Expressing an MHC Class I-restricted TCR of Nanomolar Affinity.
|
Academic Article
|
Tumour ischaemia by interferon-? resembles physiological blood vessel regression.
|
Academic Article
|
Active immunization against cancer cells: impediments and advances.
|
Academic Article
|
A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.
|
Academic Article
|
TCR-pMHC bond conformation controls TCR ligand discrimination.
|
Academic Article
|
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.
|
Academic Article
|
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.
|
Academic Article
|
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.
|
Academic Article
|
Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.
|
Academic Article
|
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
|
Academic Article
|
Automated cell cluster analysis provides insight into multi-cell-type interactions between immune cells and their targets.
|
Academic Article
|
Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.
|
Academic Article
|
Criteria to make animal studies more relevant to treating human cancer.
|
Academic Article
|
Antigen-Multimers: Specific, Sensitive, Precise, and Multifunctional High-Avidity CAR-Staining Reagents.
|
Concept
|
Histocompatibility Antigen H-2D
|
Concept
|
ErbB Receptors
|
Grant
|
Three Laser BD Digital LSR
|
Grant
|
CD8+ T cells and Immunological Tumor Regression
|
Grant
|
TRANSFORMING GENES AND IMMUNOLOGICAL TUMOR REGRESSION
|
Grant
|
Manipulation of Tumor Specific Immunity
|
Grant
|
Interdisciplinary Training Program in Immunology
|
Grant
|
IMMUNITY AND CANCER
|
Grant
|
MANIPULATION OF TUMOR-SPECIFIC IMMUNITY
|
Grant
|
Immunology of Unique Tumor Specific Antigens
|
Academic Article
|
Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model.
|